Nea Management Company, LLC Xenon Pharmaceuticals Inc. Transaction History

Nea Management Company, LLC

  • $1.31 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$15.6 - $35.4 $15.5 Million - $35.1 Million
-992,107 Closed
0 $0
Q4 2019

Jan 24, 2020
BUY
$8.11 - $14.65 $3.16 Million - $5.71 Million
389,444 Added 64.62%
992,107 $13 Million
Q3 2019

Oct 11, 2019
BUY
$8.74 - $10.51 $3.67 Million - $4.41 Million
419,909 Added 229.77%
602,663 $5.43 Million
Q2 2019

Aug 07, 2019
BUY
$8.51 - $10.75 $1.56 Million - $1.96 Million
182,754 New
182,754 $1.8 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email